What is the main purpose of the 8-K filing?

The main purpose of this 8-K filing is to inform investors about the amendment and restatement of Cardinal Health's Code of Regulations, specifically to comply with the SEC's new universal proxy rules.

How do these changes affect shareholders who want to nominate directors?

Shareholders wishing to nominate directors must now adhere to updated procedural requirements outlined in the amended regulations. This includes providing proper notice and evidence of compliance with the universal proxy rules. Failure to comply may result in the nomination being disregarded.

What are the 'universal proxy' rules?

The universal proxy rules, adopted by the SEC as Rule 14a-19, are designed to enhance shareholder democracy by ensuring that shareholders have the ability to vote by proxy for any combination of a company's director nominees and their own nominees, regardless of who solicits the proxy. The amendments help ensure Cardinal Health's procedures align with these requirements.

Are there any financial implications of these regulatory changes?

This filing is procedural and relates to corporate governance and shareholder meeting processes. It does not directly involve financial statements or announce significant financial results, so there are no immediate financial implications for investors to consider based solely on this 8-K.

CAH 8-K: Corporate Changes

Summary

Cardinal Health, Inc. (CAH) filed an 8-K on May 11, 2023, primarily to announce an amendment and restatement of its Code of Regulations, effective immediately. The core purpose of these amendments is to align the Company's procedures with the U.S. Securities and Exchange Commission's (SEC) new "universal proxy" rules (Rule 14a-19). This update is crucial for shareholders intending to nominate directors for consideration at the company's meetings.

Key Highlights

1Effective May 11, 2023, Cardinal Health amended and restated its Code of Regulations.
2The primary driver for the amendment is to comply with new SEC "universal proxy" rules (Rule 14a-19).
3The amendments clarify procedural requirements for shareholders nominating directors.
4Shareholder nominations will be disregarded if they fail to comply with universal proxy rules.
5The updated regulations address notice requirements and require evidence of compliance with universal proxy rules.
6Technical, procedural, clarifying, and conforming changes were also made to the regulations.
7The full Restated Code of Regulations is filed as an exhibit to the 8-K.

CARDINAL HEALTH INC 8-K Report, Bylaw Amendment (May 11, 2023)

Summary

Key Highlights

Frequently Asked Questions